BeOne Medicines AG
SSE:688235
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BeOne Medicines AG
SSE:688235
|
CH |
|
Imperial Equities Inc
XTSX:IEI
|
CA |
|
J
|
Jiangsu Shuangxing Color Plastic New Materials Co Ltd
SZSE:002585
|
CN |
|
Galenica AG
F:G70
|
CH |
|
C
|
Compagnie du Cambodge SA
PAR:CBDG
|
FR |
|
E
|
Energy of Minas Gerais Co
BOVESPA:CMIG3
|
BR |
Wall St Price Targets
Price Targets Summary
BeOne Medicines AG
According to Wall Street analysts, the average 1-year price target for BeOne Medicines AG is 369.84 CNY with a low forecast of 308.66 CNY and a high forecast of 476.81 CNY.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BeOne Medicines AG's stock price target?
Price Target
369.84
CNY
According to Wall Street analysts, the average 1-year price target for BeOne Medicines AG is 369.84 CNY with a low forecast of 308.66 CNY and a high forecast of 476.81 CNY.
What is the Revenue forecast for BeOne Medicines AG?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Revenue has been 53%. The projected CAGR for the next 8 years is 11%.
What is the Gross Profit forecast for BeOne Medicines AG?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 54%. The projected CAGR for the next 6 years is 10%.
What is the Operating Income forecast for BeOne Medicines AG?
Projected CAGR
33%
The compound annual growth rate for Operating Income over the next 8 years is 33%.
What is the Pre-Tax Income forecast for BeOne Medicines AG?
Projected CAGR
73%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 73%.
What is the Net Income forecast for BeOne Medicines AG?
Projected CAGR
45%
The compound annual growth rate for Net Income over the next 8 years is 45%.